Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 5/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||1941U / 2||UN / UN|
Administered by: Unknown Purchased by: Unknown
Symptoms: Chronic fatigue syndrome, Postural orthostatic tachycardia syndrome
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: diclofenac
Current Illness: Endometriosis; Human papillomavirus immunisation
Diagnostic Lab Data:
CDC 'Split Type': DK0095075131612DNK012920
Write-up:ADVERSE REACTION: Postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome. THE COURSE REGARDING THE ADVERSE REACTION: Last GARDASIL administrated on 12-MAY-2009, during the autumn of 2009 increasing symptoms. OTHER VACCINES: No. Criteria for the diagnosing of POTS: 1) Heart rate increases greater than or equal to 30 bpm from supine to standing (10 min) in the absence of orthostatic hypotension (decrease in BP greater than 20/10 mmHg). 2) Symptoms worsen with standing and improved with recumbence. 3) Symptoms last greater than or equal to 6 months. 4) Absence of other overt cause of orthostatic symptoms or tachycardia (e.g., active bleeding, acute dehydration, medications). In addition Hospital /(where the patient is followed) uses further a criterion for patients between 12-19 years: Requires a pulse increase greater than 40 bpm to make the diagnosis, with the justification, that young people have a stronger physiological pulse response to standing up. They use this additional criterion to avoid false positive.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166